technologynetworks

deCODE Launches deCODE BreastCancer™ Test to Screen for Risk of the Most Common Forms of Breast Cancer

deCODE genetics has announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can ...
EurekAlert!

deCODE BreastCancer launches, genetic test screens for risk of most common breast cancer forms

Reykjavik, ICELAND, October 8, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the ...
Reuters

Decode launches first gene test for diabetes risk

LONDON, April 15 (Reuters) - The world's first genetic test to assess the risk of individuals developing type 2 diabetes has been launched by Iceland's Decode Genetics Inc. . The biotech company, ...
Finanznachrichten

deCODE Launches a DNA-Based Test for Assessing Risk of Prostate Cancer on the Back of the Discovery of New Prostate Cancer Genes

REYKJAVIK, Iceland, Feb. 10 /PRNewswire-FirstCall/ -- deCODE genetics today announced the launch of deCODE PrCa(TM), a reference laboratory test for common, single ...
Medindia

Decoding HbA1c Test for Blood Sugar - The Underlying Principle of HbA1c

Glycosylated Hemoglobin count (Hb A molecules), a form of the hemoglobin compound, is used by doctors to identify the average level of plasma glucose concentration over an extended period of time. In ...